UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation

Cell, 2020-10, Vol.183 (2), p.490-502.e18

2020

Volltextzugriff (PDF)

Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling

Cell reports (Cambridge), 2020-06, Vol.31 (12), p.107809, Article 107809

2020

Volltextzugriff (PDF)

Design and Synthesis of Orally Bioavailable 4‑Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors

Journal of medicinal chemistry, 2016-08, Vol.59 (16), p.7651-7666

2016

Volltextzugriff (PDF)

Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction

ACS medicinal chemistry letters, 2014-09, Vol.5 (9), p.993-998

2014

Volltextzugriff (PDF)

Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors

European journal of medicinal chemistry, 2017-09, Vol.138, p.1147-1157

2017

Volltextzugriff (PDF)

Discovery of 3‑Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors

Journal of medicinal chemistry, 2020-07, Vol.63 (13), p.6876-6897

2020

Volltextzugriff (PDF)

Translation Potential and Challenges of In Vitro and Murine Models in Cancer Clinic

Cells (Basel, Switzerland), 2022-11, Vol.11 (23), p.3868

2022

Volltextzugriff (PDF)

Discovery of Imidazopyridine Derivatives as Highly Potent Respiratory Syncytial Virus Fusion Inhibitors

ACS medicinal chemistry letters, 2015-03, Vol.6 (3), p.359-362

2015

Volltextzugriff (PDF)

Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors

ACS medicinal chemistry letters, 2016-08, Vol.7 (8), p.802-806

2016

Volltextzugriff (PDF)

Discovery of Inhibitors of Soluble Epoxide Hydrolase: A Target with Multiple Potential Therapeutic Indications

Journal of medicinal chemistry, 2012-03, Vol.55 (5), p.1789-1808

2012

Volltextzugriff (PDF)

Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors

ACS medicinal chemistry letters, 2016-06, Vol.7 (6), p.558-562

2016

Volltextzugriff (PDF)

Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection

ACS infectious diseases, 2018-03, Vol.4 (3), p.257-277

2018

Volltextzugriff (PDF)

Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors

Bioorganic & medicinal chemistry letters, 2021-04, Vol.38, p.127862-127862, Article 127862

2021

Volltextzugriff (PDF)

Soluble epoxide hydrolase inhibitors: a patent review

Expert opinion on therapeutic patents, 2010-07, Vol.20 (7), p.941-956

Shen, Hong C

2010

Volltextzugriff (PDF)

Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor

Journal of medicinal chemistry, 2019-07, Vol.62 (13), p.6003-6014

2019

Volltextzugriff (PDF)

Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes

Bioorganic & medicinal chemistry letters, 2021-09, Vol.48, p.128229, Article 128229

2021

Volltextzugriff (PDF)

Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors

Bioorganic & medicinal chemistry letters, 2009-07, Vol.19 (13), p.3398-3404

2009

Volltextzugriff (PDF)

Discovery of Pyrido[2,3‑b]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV

Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.9623-9649

2020

Volltextzugriff (PDF)

Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action

Journal of medicinal chemistry, 2018-12, Vol.61 (23), p.10619-10634

2018

Volltextzugriff (PDF)

Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus

Journal of medicinal chemistry, 2023-10, Vol.66 (20), p.14116-14132

2023

Volltextzugriff (PDF)

Synthesis and biological evaluation of platensimycin analogs

Bioorganic & medicinal chemistry letters, 2009-03, Vol.19 (6), p.1623-1627

2009

Volltextzugriff (PDF)

Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection

Journal of medicinal chemistry, 2023-03, Vol.66 (6), p.4253-4270

2023

Volltextzugriff (PDF)

The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (1), p.658-665

2012

Volltextzugriff (PDF)

Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion Inhibitors

Journal of medicinal chemistry, 2018-11, Vol.61 (22), p.10228-10241

2018

Volltextzugriff (PDF)

Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus Infection

Journal of medicinal chemistry, 2022-08, Vol.65 (16), p.10938-10955

2022

Volltextzugriff (PDF)

1 – 25 von 745

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(710)
Mit Volltextzugriff
(652)

Publikationsform

Sprache

Englisch
(744)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(745)
Humans
(432)
Animals
(239)
Female
(238)
Male
(226)
Biological And Medical Sciences
(215)
Medical Sciences
(159)
Pharmacology & Pharmacy
(147)
Adult
(133)
Middle Aged
(130)
Mice
(120)
Biochemistry & Molecular Biology
(116)
Chemistry, Medicinal
(92)
Aged
(83)
Fundamental And Applied Biological Sciences. Psychology
(77)
Oncology
(75)
Physical Sciences
(67)
Rats
(63)
Chemistry
(60)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation

Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling

Design and Synthesis of Orally Bioavailable 4‑Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors

Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction

Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors

Discovery of 3‑Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors

Translation Potential and Challenges of In Vitro and Murine Models in Cancer Clinic

Discovery of Imidazopyridine Derivatives as Highly Potent Respiratory Syncytial Virus Fusion Inhibitors

Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors

Discovery of Inhibitors of Soluble Epoxide Hydrolase: A Target with Multiple Potential Therapeutic Indications

Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors

Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection

Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors

Soluble epoxide hydrolase inhibitors: a patent review

Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor

Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes

Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors

Discovery of Pyrido[2,3‑b]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV

Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action

Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus

Synthesis and biological evaluation of platensimycin analogs

Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection

The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors

Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion Inhibitors

Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus Infection

Aktive Filter

Suchergebnisse filtern